Mapping O-glycosylation of apolipoprotein C-III in MALDI-FT-ICR protein profiles

Proteomics

Volumn 13, Issue 6, 2013, Pages 992-1001

  Nicolardi, Simone ^a   Van der Burgt, Yuri E M ^a   Wuhrer, Manfred ^a   Deelder, André M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

FT ICR MS; Glycomics; Glycoproteomics; High mass accuracy; High resolution proteomics; Protein profile

Indexed keywords

APOLIPOPROTEIN C3; GLYCAN; ISOPROTEIN; SIALIC ACID;

ARTICLE; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AMINO ACID SEQUENCE; APOLIPOPROTEIN C-III; CARBOHYDRATE CONFORMATION; CHROMATOGRAPHY, REVERSE-PHASE; FOURIER ANALYSIS; GLYCOPEPTIDES; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PEPTIDE MAPPING; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SOLID PHASE EXTRACTION; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84874986856     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200293     Document Type: Article

References (47)

1. Albrethsen, J., The first decade of MALDI protein profiling: a lesson in translational biomarker research. J. Proteomics 2011, 74, 765-773.
2. Buchen, L., Missing the mark. Nature 2011, 471, 428-432.
3. Mitchell, P., Proteomics retrenches. Nat. Biotech. 2010, 28, 665-670.
4. Surinova, S., Schiess, R., Hüttenhain, R., Cerciello, F. et al., On the development of plasma protein biomarkers. J. Proteome Res. 2010, 10, 5-16.
5. Anderson, N. L., Counting the proteins in plasma. Clin. Chem. 2010, 56, 1775-1776.
6. Kulasingam, V., Pavlou, M. P., Diamandis, E. P., Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat. Rev. Cancer 2010, 10, 371-378.
7. de Noo, M. E., Tollenaar, R. A. E., Özalp, A., Kuppen, P. J. K. et al., Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry. Anal. Chem. 2005, 77, 7232-7241.
8. Villanueva, J., Lawlor, K., Toledo-Crow, R., Tempst, P., Automated serum peptide profiling. Nat. Protocols 2006, 1, 880-891.
9. Albrethsen, J., Reproducibility in protein profiling by MALDI-TOF mass spectrometry. Clin. Chem. 2007, 53, 852-858.
10. Callesen, A. K., Madsen, J. S., Vach, W., Kruse, T. A. et al., Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool? Proteomics 2009, 9, 1428-1441.
11. Pan, S., Chen, R., Brand, R. E., Hawley, S. et al., Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J. Proteome Res. 2012, 11, 1937-1948.
12. Whiteaker, J. R., Lin, C., Kennedy, J., Hou, L. et al., A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 2011, 29, 625-634.
13. Guan, S., Marshall, A. G., Scheppele, S. E., Resolution and chemical formula identification of aromatic hydrocarbons and aromatic compounds containing sulfur, nitrogen, or oxygen in petroleum distillates and refinery streams. Anal. Chem. 1996, 68, 46-71.
14. Olsen, J. V., Schwartz, J. C., Griep-Raming, J., Nielsen, M. L. et al., A dual pressure linear ion trap Orbitrap instrument with very high sequencing speed. Mol. Cell. Proteomics 2009, 8, 2759-2769.
15. Yates, J. R., Cociorva, D., Liao, L., Zabrouskov, V., Performance of a linear ion trap-Orbitrap hybrid for peptide analysis. Anal. Chem. 2005, 78, 493-500.
16. Nicolardi, S., Palmblad, M., Hensbergen, P. J., Tollenaar, R. A. E. M. et al., Precision profiling and identification of human serum peptides using Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun. Mass Spectrom. 2011, 25, 3457-3463.
17. Nedelkov, D., Phillips, D. A., Tubbs, K. A., Nelson, R. W., Investigation of human protein variants and their frequency in the general population. Mol. Cell. Proteomics 2007, 6, 1183-1187.
18. Tiss, A., Smith, C., Menon, U., Jacobs, I. et al., A well-characterised peak identification list of MALDI MS profile peaks for human blood serum. Proteomics 2010, 10, 3388-3392.
19. Hortin, G. L., The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin. Chem. 2006, 52, 1223-1237.
20. Jong, M. C., Hofker, M. H., Havekes, L. M., Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler. Thromb. Vasc. Biol. 1999, 19, 472-484.
21. Saland, J., Ginsberg, H. N., Lipoprotein metabolism in chronic renal insufficiency. Ped. Nephrol. 2007, 22, 1095-1112.
22. Gordon, S. M., Deng, J., Lu, L. J., Davidson, W. S., Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J. Proteome Res. 2010, 9, 5239-5249.
23. Shachter, N. S., Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidol. 2001, 12, 297-304.
24. Sacks, F. M., Zheng, C., Cohn, J. S., Complexities of plasma apolipoprotein C-III metabolism. J. Lipid Res. 2011, 52, 1067-1070.
25. Mauger, J.-F., Couture, P., Bergeron, N., Lamarche, B., Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism. J. Lipid Res. 2006, 47, 1212-1218.
26. Wang, C. S., McConathy, W. J., Kloer, H. U., Alaupovic, P., Modulation of lipoprotein-lipase activity by apolipoproteins - effect of apolipoprotein-C-III. J. Clin. Invest. 1985, 75, 384-390.
27. Davidsson, P., Hulthe, J., Fagerberg, B., Olsson, B.-M. et al., A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes. J. Lipid Res. 2005, 46, 1999-2006.
28. Batal, R., Tremblay, M., Barrett, P. H. R., Jacques, H. et al., Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. J. Lipid Res. 2000, 41, 706-718.
29. Onat, A., Hergenc, G., Sansoy, V., Fobker, M. et al., Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. Atherosclerosis 2003, 168, 81-89.
30. Jensen, M. K., Rimm, E. B., Furtado, J. D., Sacks, F. M., Apolipoprotein C-III as a potential modulator of the association between HDL-cholesterol and incident coronary heart disease. J. Am. Heart Assoc. 2012, 1, 1-10.
31. Cohen, M., Yossef, R., Erez, T., Kugel, A. et al., Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays. PLoS One 2011, 6, e14540.
32. Wopereis, S., Grünewald, S., Morava, É., Penzien, J. M. et al., Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. Clin. Chem. 2003, 49, 1839-1845.
33. Wopereis, S., Grünewald, S., Huijben, K. M. L. C., Morava, É. et al., Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects. Clin. Chem. 2006, 53, 180-187.
34. Brousseau, T., Clavey, V., Bard, J.-M., Fruchart, J.-C., Sequential ultracentrifugation micromethod for separation of serum-lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles. Clin. Chem. 1993, 39, 960-964.
35. Sprecher, D. L., Taam, L., Brewer, H. B., Two-dimensional electrophoresis of human-plasma apolipoproteins. Clin. Chem. 1984, 30, 2084-2092.
36. Visvikls, S., Dumon, M.-F., Steinmetz, J., Manabe, T. et al., Plasma apolipoproteins in tangier disease, as studied with two-dimensional electrophoresis. Clin. Chem. 1987, 33, 120-122.
37. Bruneel, A., Morelle, W., Carre, Y., Habarou, F. et al., Two-dimensional gel electrophoresis of apolipoprotein C-III and other serum glycoproteins for the combined screening of human congenital disorders of a and N-glycosylation. Proteomics Clin. Appl. 2007, 1, 321-324.
38. Haase, R., Menke-Möllers, I., Oette, K., Analysis of human apolipoproteins-C by isoelectric-focusing in immobilized pH gradients. Electrophoresis 1988, 9, 569-575.
39. Hancock, W. S., Bishop, C. A., Gotto, A. M., Harding, D. R. K. et al., Separation of the apoprotein components of human very low-density lipoproteins by ion-paired, reversed-phase high-performance liquid-chromatography. Lipids 1981, 16, 250-259.
40. Mazur, M. T., Cardasis, H. L., Spellman, D. S., Liaw, A. et al., Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry. Proc. Nat. Acad. Sci. USA 2010, 107, 7728-7733.
41. Nelsestuen, G. L., Zhang, Y., Martinez, M. B., Key, N. S. et al., Plasma protein profiling: unique and stable features of individuals. Proteomics 2005, 5, 4012-4024.
42. Jimenez, C. R., El Filali, Z., Knol, J. C., Hoekman, K. et al., Automated-serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS. Proteomics Clin. Appl. 2007, 1, 598-604.
43. Wada, Y., Kadoya, M., Okamoto, N., Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation, and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient. Glycobiology 2012, 22, 1140-1144.
44. Nicolardi, S., Palmblad, M., Dalebout, H., Bladergroen, M. et al., Quality control based on isotopic distributions for high-throughput MALDI-TOF and MALDI-FTICR serum peptide profiling. J. Am. Soc. Mass Spectrom. 2010, 21, 1515-1525.
45. Bladergroen, M. R., Derks, R. J. E., Nicolardi, S., de Visser, B. et al., Standardized and automated solid-phase extraction procedures for high-throughput proteomics of body fluids. J. Proteomics 2012, 77, 144-153.
46. Nicolardi, S., Dalebout, H., Bladergroen, M. R., Mesker, W. E. et al., Identification of human serum peptides in Fourier transform ion cyclotron resonance precision profiles. Int. J. Proteomics 2012, 6, 804036.
47. Selman, M. H. J., McDonnell, L. A., Palmblad, M., Ruhaak, L. R., Deelder, immunoglobulin G glycopeptide profiling by matrix-assisted laser desorption ionization fourier transform ion cyclotron resonance mass spectrometry. Anal. Chem. 2010, 82, 1073-1081.